The Association of Public Health Laboratories (APHL) is proud to announce that we will once again offer a limited number of travel scholarships to support attendance at the 2019 HIV Diagnostics Conference, March 25–28, 2019 at the Marriott Marquis in Atlanta, Georgia.
Travel Scholarship Information
• Public health laboratorians, epidemiologists, and health department prevention and surveillance programmatic staff that are planning to attend the 2019 HIV Diagnostics Conference are all eligible to apply for an APHL Travel Scholarship.
• In order to take advantage of this opportunity please complete the application form by November 30, 2018.
• Due to the limited number of scholarships, preference will be given to attendees selected to present posters at the conference (attendees selected for oral presentations will be traveled through the conference).
◦ If additional funds are available consideration will be given to
- Attendees submitting a late breaker abstract
- Attendees new to their position (less than 2 years)
- Attendees from organizations planning to implement new testing technologies or approaches
• Awardees will be notified by December 21, 2018. If we are unable to make a determination by that point, APHL will communicate with all applicants with an updated timeline.
• APHL will provide with additional instructions on how to make their travel arrangements, meeting registration and any other questions.
At this time APHL plans to select around 30 scholarship recipients but if more funding becomes available we will select additional applicants from this pool so it is important that if you think you may need funding to complete the application by November 30, 2018.
If you have any questions about completing the application, please feel free to contact my colleague Hannah Asmail (email@example.com).
The 2019 HIV Diagnostics Conference has an expanded scope and theme of “Optimizing Testing for HIV, STIs and HCV in Laboratories, Public Health Programs and Clinical Practice.” Attendees will become familiar with test performance data, best practices, and implementation of testing algorithms, quality assurance, and the application of newer tests in a variety of settings. Past conferences have fostered the development and use of new HIV testing technology in the United States. Attendees will include public health officials, laboratorians, HIV/STI/HCV testing program managers, surveillance coordinators and industry representatives.
If you have any questions about this conference funding opportunity, please don’t hesitate to contact me.
Anne M. Gaynor, PhD
Manager, HIV, Hepatitis, STD and TB Programs